$549 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 83 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | ARBE ROBOTICS LTDordinary shares | $0 | – | -43,165 | -100.0% | -0.02% | – | |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.02% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -1,476,000 | -100.0% | -0.05% | – |
| PMVP | Exit | PMV PHARMACEUTICALS INC | $0 | – | -187,800 | -100.0% | -0.18% | – |
| DYN | Exit | DYNE THERAPEUTICS INC | $0 | – | -119,918 | -100.0% | -0.21% | – |
| MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -418,562 | -100.0% | -0.22% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -500,000 | -100.0% | -0.28% | – |
| BBIO | Exit | BRIDGEBIO PHARMA INCcall | $0 | – | -130,000 | -100.0% | -0.35% | – |
| Exit | ARCELLX INC | $0 | – | -77,488 | -100.0% | -0.38% | – | |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -213,462 | -100.0% | -0.51% | – |
| Exit | ENLIGHT RENEWABLE ENERGY LTD | $0 | – | -211,586 | -100.0% | -0.59% | – | |
| QCOM | Exit | QUALCOMM INC | $0 | – | -32,000 | -100.0% | -0.60% | – |
| ARGX | Exit | ARGENX SEput | $0 | – | -10,000 | -100.0% | -0.61% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -134,414 | -100.0% | -0.83% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -128,000 | -100.0% | -0.94% | – |
| ENPH | Exit | ENPHASE ENERGY INCcall | $0 | – | -40,000 | -100.0% | -1.05% | – |
| CAMT | Exit | CAMTEK LTDord | $0 | – | -189,494 | -100.0% | -1.05% | – |
| MSFT | Exit | MICROSOFT CORPcall | $0 | – | -21,000 | -100.0% | -1.12% | – |
| GNRC | Exit | GENERAC HLDGS INCcall | $0 | – | -52,500 | -100.0% | -1.22% | – |
| NVMI | Exit | NOVA LTD | $0 | – | -70,000 | -100.0% | -1.28% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -78,300 | -100.0% | -1.40% | – |
| TSEM | Exit | TOWER SEMICONDUCTOR LTDput | $0 | – | -332,100 | -100.0% | -1.95% | – |
| AMD | Exit | ADVANCED MICRO DEVICES INCcall | $0 | – | -120,000 | -100.0% | -2.13% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -126,000 | -100.0% | -7.27% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICAL-SP ADR | 36 | Q3 2023 | 8.4% |
| MERCK & CO INC NEW | 35 | Q3 2023 | 8.4% |
| NICE Systems Ltd | 27 | Q3 2023 | 4.4% |
| BIOGEN INC | 26 | Q3 2023 | 6.7% |
| AMICUS THERAPEUTICS INC | 26 | Q2 2022 | 4.3% |
| PFIZER INC | 25 | Q3 2023 | 9.2% |
| SAREPTA THERAPEUTICS INC | 25 | Q3 2023 | 3.2% |
| JOHNSON & JOHNSON | 24 | Q3 2023 | 8.0% |
| UNIQURE NV | 23 | Q3 2023 | 1.2% |
| SYNDAX PHARMACEUTICALS INC | 22 | Q3 2023 | 3.9% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyclacel Pharmaceuticals, Inc. | February 06, 2023 | 250,000 | 2.0% |
| Altimmune, Inc. | February 14, 2022 | 1,244,241 | 3.1% |
| Allot Ltd. | February 16, 2021 | 1,129,054 | 3.2% |
| Larimar Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Neos Therapeutics, Inc. | February 16, 2021 | ? | ? |
| Orgenesis Inc. | February 16, 2021 | 525,216 | 0.0% |
| Sio Gene Therapies Inc. | February 16, 2021 | ? | ? |
| X4 Pharmaceuticals, Inc | February 16, 2021 | 250,000 | 0.0% |
| Axovant Gene Therapies Ltd. | February 25, 2020 | 2,931,017 | 8.0% |
| Axovant Gene Therapies Ltd. | February 11, 2020 | 398,540 | 1.8% |
View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-02-08 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-10 |
| SC 13G | 2023-08-30 |
View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.